triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv infektioner - antivirale midler til systemisk anvendelse - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
vantavo (previously alendronate sodium and colecalciferol, msd)
n.v. organon - alendronsyre, colecalciferol - osteoporose, postmenopausale - narkotika til behandling af knoglesygdomme - behandling af postmenopausal osteoporose hos patienter med risiko for vitamin d-insufficiens. vantavo reducerer risikoen for vertebrale og hoftebrud. behandling af postmenopausal osteoporose hos patienter, der ikke får d-vitamin d-tilskud, og er i risiko for d-vitamin d-insufficiens. vantavo reducerer risikoen for vertebrale og hoftebrud.
depakine chrono 300 mg depottabletter
orifarm a/s - natriumvalproat, valproinsyre - depottabletter - 300 mg
orfiril long 150 mg depotkapsler, hårde
paranova danmark a/s - natriumvalproat - depotkapsler, hårde - 150 mg
delepsine 100 mg enterotabletter
orion corporation - natriumvalproat - enterotabletter - 100 mg
delepsine 200 mg/ml orale dråber, opløsning
orion corporation - natriumvalproat - orale dråber, opløsning - 200 mg/ml
delepsine 60 mg/ml oral opløsning
orion corporation - natriumvalproat - oral opløsning - 60 mg/ml
delepsine 300 mg suppositorier
orion corporation - natriumvalproat - suppositorier - 300 mg
delepsine retard 300 mg depottabletter
orion corporation - natriumvalproat - depottabletter - 300 mg
depakine retard 500 mg depottabletter
2care4 aps - natriumvalproat, valproinsyre - depottabletter - 500 mg